NCT07636863已完成不适用
Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig by Early Adopters
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年8月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
- 试验地点
- 1
研究概览
简要总结
This study will review medical records of adults with cancer who received nivolumab either as an intravenous (IV) infusion or as a subcutaneous (under the skin) injection in community oncology clinics in the United States. The study will describe who receives each type of treatment, how the treatments are used, and selected safety events such as reactions at the injection or infusion site and infections.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Are ≥ 18 years of age at the index date
- •Have a confirmed cancer diagnosis
- •Received one of the following treatments:
- •Intravenous (IV) nivolumab
- •Subcutaneous (SC) nivolumab + hyaluronidase
排除标准
- •Currently receiving a clinical trial therapy at index
- •Currently receiving treatment for another active concurrent primary cancer diagnosis
- •Received IV nivolumab or SC nivolumab + hyaluronidase off-label
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Pan tumor Roll Over Study2023-506914-32-00Bristol Myers Squibb International Corporation306
招募中
2 期
Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHLHodgkin LymphomaNCT07551583M.D. Anderson Cancer Center15
Enrolling By Invitation
2 期
Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR CancersColorectal CancerGastric CancerNCT07542262Blokhin's Russian Cancer Research Center128
招募中
1 期
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma2025-524953-15-00Region Hovedstaden15
已完成
2 期
A Study of Nivolumab and Nivolumab Combinations in Recurrent and Metastatic Colon Cancer2024-516004-42-01Bristol Myers Squibb International Corporation143